Treatment modalities for coronavirus disease 2019 (COVID-19)
Management of coronavirus disease 2019 (COVID-19) infection is based on limited data and keeps changing rapidly as new clinical data emerge. Remdesivir has shown to reduce duration of hospital stay and has been approved for treatment. In RECOVERY trial, corticosteroids lowered 28-day mortality in pa...
Main Author: | Panduranga G |
---|---|
Format: | Article |
Language: | English |
Published: |
KIMS Foundation and Research Center
2020-12-01
|
Series: | Journal of Medical and Scientific Research |
Subjects: | |
Online Access: | http://jmsronline.com/article.aspx?ID=Treatment-modalities-for-coronavirus-disease-2019-COVID-19 |
Similar Items
-
Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients
by: Sahar K. Hegazy, et al.
Published: (2023-06-01) -
COVID-19 Hastalarında Lopinavir/Ritonavir ve Favipravir Deneyimi
by: Esma Eroğlu, et al.
Published: (2020-12-01) -
COVID-19 Hastalarında Lopinavir/Ritonavir ve Favipravir Deneyimi
by: Esma Eroğlu, et al.
Published: (2020-12-01) -
Experimental therapies under investigation for COVID-19
by: Reshma Golamari, et al.
Published: (2021-03-01) -
Doxycycline as a potential partner of COVID-19 therapies
by: Alexandre E. Malek, et al.
Published: (2020-01-01)